{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T10:42:06Z","timestamp":1780396926947,"version":"3.54.1"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2024,4,23]],"date-time":"2024-04-23T00:00:00Z","timestamp":1713830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,4,23]],"date-time":"2024-04-23T00:00:00Z","timestamp":1713830400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002386","name":"Cairo University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002386","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2024,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The clinical usage of doxorubicin (DOX) is hampered due to cardiomyopathy. Studies reveal that estrogen (E2) modulates DOX-induced cardiotoxicity. Yet, the exact mechanism is unclear. The objective of the current study is to evaluate the influence of E2 and more specifically its metabolite 2-methoxyestradiol (2ME) on cardiac remodeling and the reprogramming of cardiac metabolism in rats subjected to DOX cardiotoxicity. Seventy-two female rats were divided into groups. Cardiotoxicity was induced by administering DOX (2.5 mg\/kg three times weekly for 2 weeks). In some groups, the effect of endogenous E2 was abolished by ovariectomy (OVX) or by using the estrogen receptor (ER) blocker Fulvestrant (FULV). The effect of administering exogenous E2 or 2ME in the OVX group was studied. Furthermore, the influence of entacapone (COMT inhibitor) on induced cardiotoxicity was investigated. The evaluated cardiac parameters included ECG, histopathology, cardiac-related enzymes (creatine kinase isoenzyme-MB (CK-MB) and lactate dehydrogenase (LDH)), and lipid profile markers (total cholesterol (TC), triglyceride (TG), and high-density lipoprotein (HDL)). The expression levels of key metabolic enzymes (glucose transporter-4 (GLUT4) and carnitine palmitoyltransferase-1B (CPT-1B)) were assessed. Our results displayed that co-treatment of E2 and\/or 2ME with DOX significantly reduced DOX-induced cardiomyopathy and enhanced the metabolism of the heart through the maintenance of GLUT4 and CPT-1B enzymes. On the other hand, co-treatment of DOX with OVX, entacapone, or FULV increased the toxic effect of DOX by further reducing these important metabolic enzymes. E2 and 2ME abrogate DOX-induced cardiomyopathy partly through modulation of GLUT 4 and CPT-1B enzymes.<\/jats:p>\n                <jats:p><jats:bold>Graphical Abstract<\/jats:bold><\/jats:p>","DOI":"10.1007\/s00210-024-03073-z","type":"journal-article","created":{"date-parts":[[2024,4,23]],"date-time":"2024-04-23T13:01:48Z","timestamp":1713877308000},"page":"7129-7139","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["2-Methoxyestradiol ameliorates doxorubicin-induced cardiotoxicity by regulating the expression of GLUT4 and CPT-1B in female rats"],"prefix":"10.1007","volume":"397","author":[{"given":"Mohamed H.","family":"Sobhy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Ismail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed S.","family":"Abdel-Hamid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Wagih","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1372-8554","authenticated-orcid":false,"given":"Marwa","family":"Kamel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,4,23]]},"reference":[{"key":"3073_CR1","doi-asserted-by":"publisher","first-page":"117082","DOI":"10.1016\/j.lfs.2019.117082","volume":"239","author":"S Abd El-Lateef","year":"2019","unstructured":"Abd El-Lateef S, El-Sayed MA, Salama S (2019) The protective role of estrogen and its receptors in gentamicin-induced acute kidney injury in rats. Life Sci 239:117082. https:\/\/doi.org\/10.1016\/j.lfs.2019.117082","journal-title":"Life Sci"},{"issue":"2","key":"3073_CR2","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1177\/1078155219877931","volume":"26","author":"HS Al-Malky","year":"2020","unstructured":"Al-Malky HS, Al Harthi SE, Osman AM (2020) Major obstacles to doxorubicin therapy: cardiotoxicity and drug resistance. J Oncol Pharm Pract 26(2):434\u2013444. https:\/\/doi.org\/10.1177\/1078155219877931","journal-title":"J Oncol Pharm Pract"},{"key":"3073_CR3","doi-asserted-by":"publisher","first-page":"619185","DOI":"10.1155\/2012\/619185","volume":"2012","author":"O Al-Shabanah","year":"2012","unstructured":"Al-Shabanah O, Aleisa A, Hafez M, Al-Rejaie S, Al-Yahya A, Bakheet S, Al-Harbi M, Sayed-Ahmed M (2012) Desferrioxamine attenuates doxorubicin-induced acute cardiotoxicity through TFG-\u03b2\/Smad p53 pathway in rat model. Oxid Med Cell Longev 2012:619185. https:\/\/doi.org\/10.1155\/2012\/619185","journal-title":"Oxid Med Cell Longev"},{"issue":"4","key":"3073_CR4","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1158\/1078-0432.CCR-08-1599","volume":"15","author":"JT Amye","year":"2009","unstructured":"Amye JT, Kyle DH, Dona BA, Carolyn S, Jamie A, Check Q, George W, Glenn L (2009) Phase I trial of 2-methoxyestradiol NanoCrystal dispersion in advanced solid malignancies. Clin Cancer Res 15(4):1460\u20135. https:\/\/doi.org\/10.1158\/1078-0432.CCR-08-1599","journal-title":"Clin Cancer Res"},{"issue":"1","key":"3073_CR5","doi-asserted-by":"publisher","first-page":"62","DOI":"10.5935\/abc.20160005","volume":"106","author":"PS Azevedo","year":"2016","unstructured":"Azevedo PS, Polegato BF, Minicucci MF, Paiva SA, Zornoff LA (2016) Cardiac remodeling: concepts, clinical impact, pathophysiological mechanisms and pharmacologic treatment. Arq Bras Cardiol 106(1):62\u20139. https:\/\/doi.org\/10.5935\/abc.20160005","journal-title":"Arq Bras Cardiol"},{"issue":"1","key":"3073_CR6","doi-asserted-by":"publisher","first-page":"55","DOI":"10.22092\/ari.2019.116862.1177","volume":"75","author":"H Babaei","year":"2020","unstructured":"Babaei H, Razmaraii N, Assadnassab G, Mohajjel NA, Azarmi Y, Mohammadnejad D, Azami A (2020) Ultrastructural and echocardiographic assessment of chronic doxorubicin-induced cardiotoxicity in rats. Archives of Razi Institute 75(1):55\u201362. https:\/\/doi.org\/10.22092\/ari.2019.116862.1177","journal-title":"Archives of Razi Institute"},{"issue":"3","key":"3073_CR7","doi-asserted-by":"publisher","first-page":"e0151548","DOI":"10.1371\/journal.pone.0151548","volume":"11","author":"LA Biondo","year":"2016","unstructured":"Biondo LA, Lima Junior EA, Souza CO, Cruz MM, Cunha RD, Alonso-Vale MI, Oyama LM, Nascimento CM, Pimentel GD, Dos Santos RV, Rosa LFS, Neto JC (2016) Impact of doxorubicin treatment on the physiological functions of white adipose tissue. PloS one 11(3):e0151548. https:\/\/doi.org\/10.1371\/journal.pone.0151548","journal-title":"PloS one"},{"issue":"4","key":"3073_CR8","doi-asserted-by":"publisher","first-page":"521","DOI":"10.24425\/pjvs.2020.134701","volume":"23","author":"C Boonyapakorn","year":"2020","unstructured":"Boonyapakorn C, Punyapornwithaya V, Sawatphakdee G, Poolsawat N, Pongkan W (2020) Estrogen deprivation induces lipid profile impairment but not cardiac dysfunction in ovariohysterectomized dogs. Polish J Veterin Sci 23(4):521\u2013528. https:\/\/doi.org\/10.24425\/pjvs.2020.134701","journal-title":"Polish J Veterin Sci"},{"issue":"9","key":"3073_CR9","doi-asserted-by":"publisher","first-page":"4128","DOI":"10.1210\/en.2007-0259","volume":"148","author":"J Bourghardt","year":"2007","unstructured":"Bourghardt J, Bergstr\u00f6m G, Krettek A, Sj\u00f6berg S, Bor\u00e9n J, Tivesten A (2007) The endogenous estradiol metabolite 2-methoxyestradiol reduces atherosclerotic lesion formation in female apolipoprotein E-deficient mice. Endocrinology 148(9):4128\u20134132. https:\/\/doi.org\/10.1210\/en.2007-0259","journal-title":"Endocrinology"},{"issue":"4","key":"3073_CR10","doi-asserted-by":"publisher","first-page":"E803","DOI":"10.1152\/ajpendo.2001.281.4.E803","volume":"281","author":"SE Campbell","year":"2001","unstructured":"Campbell SE, Febbraio M (2001) Effect of ovarian hormones on mitochondrial enzyme activity in the fat oxidation pathway of skeletal muscle. Am J Physiol Endocrinol Metab 281(4):E803\u2013E808. https:\/\/doi.org\/10.1152\/ajpendo.2001.281.4.E803","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"3","key":"3073_CR11","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1530\/JME-17-0041","volume":"59","author":"RS Campello","year":"2017","unstructured":"Campello RS, F\u00e1tima LA, Barreto-Andrade JN, Lucas TF, Mori RC, Porto CS, Machado UF (2017) Estradiol-induced regulation of GLUT4 in 3T3-L1 cells: involvement of ESR1 and AKT activation. J Mol Endocrinol 59(3):257\u2013268. https:\/\/doi.org\/10.1530\/JME-17-0041","journal-title":"J Mol Endocrinol"},{"key":"3073_CR12","doi-asserted-by":"publisher","first-page":"431524","DOI":"10.1155\/2014\/431524","volume":"2014","author":"YY Chen","year":"2014","unstructured":"Chen YY, Yeh CH, So EC, Sun DP, Wang LY, Hsing CH (2014) Anticancer drug 2-methoxyestradiol protects against renal ischemia\/reperfusion injury by reducing inflammatory cytokines expression. BioMed Res Int 2014:431524. https:\/\/doi.org\/10.1155\/2014\/431524","journal-title":"BioMed Res Int"},{"issue":"6","key":"3073_CR13","doi-asserted-by":"publisher","first-page":"H1459","DOI":"10.1152\/ajpheart.00247.2020","volume":"319","author":"TC Cheng","year":"2020","unstructured":"Cheng TC, Phili JL, Tabima DM, Kumari S, Yakubov B, Frump AL, Hacker T, Bellofiore A, Li R, Sun X, Goss KN, Lahm T, Chesler NC (2020) Estrogen receptor-\u03b1 prevents right ventricular diastolic dysfunction and fibrosis in female rats. Am J Physiol Heart Circulat Physiol 319(6):H1459\u2013H1473. https:\/\/doi.org\/10.1152\/ajpheart.00247.2020","journal-title":"Am J Physiol Heart Circulat Physiol"},{"issue":"11","key":"3073_CR14","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1016\/j.nutres.2012.10.002","volume":"32","author":"JS Choi","year":"2012","unstructured":"Choi JS, Koh IU, Song J (2012) Genistein reduced insulin resistance index through modulating lipid metabolism in ovariectomized rats. Nutr Res (New York, N.Y.) 32(11):844\u2013855. https:\/\/doi.org\/10.1016\/j.nutres.2012.10.002","journal-title":"Nutr Res (New York, N.Y.)"},{"issue":"10","key":"3073_CR15","doi-asserted-by":"publisher","first-page":"2177","DOI":"10.3390\/cells9102177","volume":"9","author":"M Dallons","year":"2020","unstructured":"Dallons M, Alpan E, Schepkens C, Tagliatt V, Colet JM (2020) GPR91 receptor mediates protection against doxorubicin-induced cardiotoxicity without altering its anticancer efficacy. An in vitro study on H9C2 cardiomyoblasts and breast cancer-derived MCF-7 cells. Cells 9(10):2177. https:\/\/doi.org\/10.3390\/cells9102177","journal-title":"Cells"},{"issue":"1","key":"3073_CR16","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.ygyno.2009.05.042","volume":"115","author":"M Daniela","year":"2009","unstructured":"Daniela M, Jeanne S, Gregory S, Susan P, Tim B, Check Q, Carolyn S (2009) Activity of 2 methoxyestradiol (Panzem NCD) in advanced Gynecol Oncol, platinum-resistant ovarian cancer and primary peritoneal carcinomatosis: a Hoosier Oncology Group trial. Gynecol Oncol 115(1):90\u201396. https:\/\/doi.org\/10.1016\/j.ygyno.2009.05.042","journal-title":"Gynecol Oncol"},{"issue":"5","key":"3073_CR17","doi-asserted-by":"publisher","first-page":"e011628","DOI":"10.1161\/JAHA.118.011628","volume":"8","author":"CK Docherty","year":"2019","unstructured":"Docherty CK, Nilsen M, MacLean MR (2019) Influence of 2-methoxyestradiol and sex on hypoxia-induced pulmonary hypertension and hypoxia-inducible factor-1-\u03b1. J Am Heart Assoc 8(5):e011628. https:\/\/doi.org\/10.1161\/JAHA.118.011628","journal-title":"J Am Heart Assoc"},{"key":"3073_CR18","doi-asserted-by":"publisher","first-page":"117743","DOI":"10.1016\/j.lfs.2020.117743","volume":"255","author":"MMA Elzayat","year":"2020","unstructured":"Elzayat MMA, Bayoumi AM, Abdel-Bakky MS, Mansour AM, Kamel M, Abo-Saif A, Allam S, Salama SA (2020) Ameliorative effect of 2-methoxyestradiol on radiation-induced lung injury. Life Sci 255:117743. https:\/\/doi.org\/10.1016\/j.lfs.2020.117743","journal-title":"Life Sci"},{"issue":"1","key":"3073_CR19","doi-asserted-by":"publisher","first-page":"99","DOI":"10.3390\/cells10010099","volume":"10","author":"KC Gregorio","year":"2021","unstructured":"Gregorio KC, Laurindo CP, Machado UF (2021) Estrogen and glycemic homeostasis: the fundamental role of nuclear estrogen receptors ESR1\/ESR2 in glucose transporter GLUT4 regulation. Cells 10(1):99. https:\/\/doi.org\/10.3390\/cells10010099","journal-title":"Cells"},{"issue":"8","key":"3073_CR20","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1111\/dom.12248","volume":"16","author":"KR Haynie","year":"2014","unstructured":"Haynie KR, Vandanmagsar B, Wicks SE, Zhang J, Mynatt RL (2014) Inhibition of carnitine palymitoyltransferase1b induces cardiac hypertrophy and mortality in mice. Diabetes Obes Metab 16(8):757\u2013760. https:\/\/doi.org\/10.1111\/dom.12248","journal-title":"Diabetes Obes Metab"},{"issue":"14","key":"3073_CR21","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1161\/CIRCULATIONAHA.111.075978","volume":"126","author":"L He","year":"2012","unstructured":"He L, Kim T, Long Q, Liu J, Wang P, Zhou Y, Ding Y, Prasain J, Wood PA, Yang Q (2012) Carnitine palmitoyltransferase-1b deficiency aggravates pressure overload-induced cardiac hypertrophy caused by lipotoxicity. Circulation 126(14):1705\u20131716. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.111.075978","journal-title":"Circulation"},{"issue":"4","key":"3073_CR22","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1080\/09687680110090456","volume":"18","author":"HG Joost","year":"2001","unstructured":"Joost HG, Thorens B (2001) The extended GLUT-family of sugar\/polyol transport facilitators: nomenclature, sequence characteristics, and potential function of its novel members (review). Mol Membr Biol 18(4):247\u2013256. https:\/\/doi.org\/10.1080\/09687680110090456","journal-title":"Mol Membr Biol"},{"issue":"8","key":"3073_CR23","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.3390\/molecules25081784","volume":"25","author":"PR Joshi","year":"2020","unstructured":"Joshi PR, Zierz S (2020) Muscle carnitine palmitoyltransferase II (CPT II) deficiency: a conceptual approach. Molecules (Basel, Switzerland) 25(8):1784. https:\/\/doi.org\/10.3390\/molecules25081784","journal-title":"Molecules (Basel, Switzerland)"},{"issue":"1","key":"3073_CR24","doi-asserted-by":"publisher","first-page":"7927","DOI":"10.1038\/s41598-017-08513-w","volume":"7","author":"M Kanasaki","year":"2017","unstructured":"Kanasaki M, Srivastava SP, Yang F, Xu L, Kudoh S, Kitada M, Ueki N, Kim H, Li J, Takeda S, Kanasaki K, Koya D (2017) Deficiency in catechol-o-methyltransferase is linked to a disruption of glucose homeostasis in mice. Sci Rep 7(1):7927. https:\/\/doi.org\/10.1038\/s41598-017-08513-w","journal-title":"Sci Rep"},{"issue":"3","key":"3073_CR25","first-page":"462","volume":"52","author":"DK Khajuria","year":"2012","unstructured":"Khajuria DK, Razdan R, Mahapatra DR (2012) Description of a new method of ovariectomy in female rats. Rev Brasileira de Reumatologia 52(3):462\u2013470","journal-title":"Rev Brasileira de Reumatologia"},{"issue":"13","key":"3073_CR26","first-page":"3691","volume":"62","author":"TM LaVallee","year":"2002","unstructured":"LaVallee TM, Zhan XH, Herbstritt CJ, Kough EC, Green SJ, Pribluda VS (2002) 2-Methoxyestradiol inhibits proliferation and induces apoptosis independently of estrogen receptors alpha and beta. Cancer Res 62(13):3691\u20133697","journal-title":"Cancer Res"},{"issue":"1","key":"3073_CR27","first-page":"561","volume":"286","author":"D Liu","year":"1998","unstructured":"Liu D, Bachmann KA (1998) An investigation of the relationship between estrogen, estrogen metabolites and blood cholesterol levels in ovariectomized rats. J Pharmacol Exper Therap 286(1):561\u2013568","journal-title":"J Pharmacol Exper Therap"},{"key":"3073_CR28","doi-asserted-by":"publisher","first-page":"603596","DOI":"10.3389\/fphar.2020.603596","volume":"11","author":"Y Liu","year":"2021","unstructured":"Liu Y, Wei X, Wu M, Xu J, Xu B, Kang L (2021) Cardioprotective roles of \u03b2-hydroxybutyrate against doxorubicin induced cardiotoxicity. Front Pharmacol 11:603596. https:\/\/doi.org\/10.3389\/fphar.2020.603596","journal-title":"Front Pharmacol"},{"issue":"1","key":"3073_CR29","doi-asserted-by":"publisher","first-page":"2780","DOI":"10.1038\/s41598-018-20613-9","volume":"8","author":"ZH Maayah","year":"2018","unstructured":"Maayah ZH, Levasseur J, Siva Piragasam R, Abdelhamid G, Dyck JR, Fahlman RP, Siraki AG, El-Kadi AOS (2018) 2-Methoxyestradiol protects against pressure overload-induced left ventricular hypertrophy. Sci orts 8(1):2780. https:\/\/doi.org\/10.1038\/s41598-018-20613-9","journal-title":"Sci orts"},{"key":"3073_CR30","doi-asserted-by":"publisher","first-page":"146365","DOI":"10.1016\/j.gene.2022.146365","volume":"823","author":"N Maleki","year":"2022","unstructured":"Maleki N, Khosh Ravesh R, Salehiyeh S, Faisal Faiz A, Ebrahimi M, Sharbati A, Panji M, Ajami KH, Safizadeh F, Abbasi M, Abazari O, Norbakhsh R, Eskandari Y (2022) Comparative effects of estrogen and silibinin on cardiovascular risk biomarkers in ovariectomized rats. Gene 823:146365. https:\/\/doi.org\/10.1016\/j.gene.2022.146365","journal-title":"Gene"},{"issue":"1","key":"3073_CR31","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s11745-011-3600-y","volume":"47","author":"CM Masi","year":"2012","unstructured":"Masi CM, Hawkley LC, Cacioppo JT (2012) Serum 2-methoxyestradiol, an estrogen metabolite, is positively associated with serum HDL-C in a population-based sample. Lipids 47(1):35\u201338. https:\/\/doi.org\/10.1007\/s11745-011-3600-y","journal-title":"Lipids"},{"issue":"1","key":"3073_CR32","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s13293-018-0198-2","volume":"9","author":"B Meiners","year":"2018","unstructured":"Meiners B, Shenoy C, Zordoky BN (2018) Clinical and preclinical evidence of sex-related differences in anthracycline-induced cardiotoxicity. Biol Sex Diff 9(1):38. https:\/\/doi.org\/10.1186\/s13293-018-0198-2","journal-title":"Biol Sex Diff"},{"issue":"4","key":"3073_CR33","doi-asserted-by":"publisher","first-page":"273","DOI":"10.4155\/fmc-2019-0258","volume":"12","author":"B Mengyu","year":"2020","unstructured":"Mengyu B, Yongtao D (2020) Advance of 2-methoxyestradiol as a promising anticancer agent for cancer therapy. Future Med Chem 12(4):273\u2013275. https:\/\/doi.org\/10.4155\/fmc-2019-0258","journal-title":"Future Med Chem"},{"issue":"1","key":"3073_CR34","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1161\/CIRCHEARTFAILURE.114.001180","volume":"8","author":"M Moulin","year":"2015","unstructured":"Moulin M, Piquereau J, Mateo P, Fortin D, Rucker-Martin C, Gressette M, Lefebvre F, Gresikova M, Solgadi A, Veksler V, Garnier A, Ventua-Clapier R (2015) Sexual dimorphism of doxorubicin-mediated cardiotoxicity: potential role of energy metabolism remodeling. Circ Heart Failure 8(1):98\u2013108. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.114.001180","journal-title":"Circ Heart Failure"},{"issue":"10","key":"3073_CR35","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.steroids.2010.02.016","volume":"75","author":"AO Mueck","year":"2010","unstructured":"Mueck AO, Seeger H (2010) 2-Methoxyestradiol\u2014biology and mechanism of action. Steroids 75(10):625\u2013631. https:\/\/doi.org\/10.1016\/j.steroids.2010.02.016","journal-title":"Steroids"},{"issue":"3","key":"3073_CR36","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1002\/path.5192","volume":"247","author":"C Ni","year":"2019","unstructured":"Ni C, Ma P, Wang R, Lou X, Liu X, Xue Qin Y, Blasig I, Erben U, Qin Z (2019) Doxorubicin-induced cardiotoxicity involves IFN\u03b3-mediated metabolic reprogramming in cardiomyocytes. J Pathol 247(3):320\u2013332. https:\/\/doi.org\/10.1002\/path.5192","journal-title":"J Pathol"},{"issue":"6","key":"3073_CR37","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1016\/j.yjmcc.2012.03.006","volume":"52","author":"Y Octavia","year":"2012","unstructured":"Octavia Y, Tocchetti G, Gabrielson K, Janssens S, Crijns HJ, Moens AL (2012) Doxorubicin-induced cardiomyopathy: from molecular mechanisms to therapeutic strategies. J Mol Cell Cardiol 52(6):1213\u20131225. https:\/\/doi.org\/10.1016\/j.yjmcc.2012.03.006","journal-title":"J Mol Cell Cardiol"},{"issue":"9","key":"3073_CR38","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1007\/s12012-022-09762-6","volume":"22","author":"T Panpan","year":"2022","unstructured":"Panpan T, Yuchen D, Xianyong S, Meng L, Ruijuan H, Ranran D, Pengyan Z, Mingxi L, Rongrong X (2022) Cardiac remodelling following cancer therapy: a review. Cardiovasc Toxicol. 22(9):771\u2013786. https:\/\/doi.org\/10.1007\/s12012-022-09762-6","journal-title":"Cardiovasc Toxicol."},{"issue":"1","key":"3073_CR39","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s13293-018-0183-9","volume":"9","author":"KL Pokrzywinski","year":"2018","unstructured":"Pokrzywinski KL, Biel TG, Rosen ET, Bonanno JL, Aryal B, Mascia F, Moshkelani D, Mog S, Rao VA (2018) Doxorubicin-induced cardiotoxicity is suppressed by estrous-staged treatment and exogenous 17\u03b2-estradiol in female tumor-bearing spontaneously hypertensive rats. Biol Sex Diff 9(1):25. https:\/\/doi.org\/10.1186\/s13293-018-0183-9","journal-title":"Biol Sex Diff"},{"issue":"2","key":"3073_CR40","doi-asserted-by":"publisher","first-page":"H360","DOI":"10.1152\/ajpheart.00428.2018","volume":"316","author":"C Rattanasopa","year":"2019","unstructured":"Rattanasopa C, Kirk J, Bupha-Intr T, Papadaki M, de Tombe PP, Wattanapermpool J (2019) Estrogen but not testosterone preserves myofilament function from doxorubicin-induced cardiotoxicity by reducing oxidative modifications. Am J Physiol Heart Circulat Physiol 316(2):H360\u2013H370. https:\/\/doi.org\/10.1152\/ajpheart.00428.2018","journal-title":"Am J Physiol Heart Circulat Physiol"},{"key":"3073_CR41","doi-asserted-by":"publisher","first-page":"111708","DOI":"10.1016\/j.biopha.2021.111708","volume":"139","author":"PS Rawat","year":"2021","unstructured":"Rawat PS, Jaiswa A, Khurana A, Bhatti JS, Navik U (2021) Doxorubicin-induced cardiotoxicity: an update on the molecular mechanism and novel therapeutic strategies for effective management. Biomed Pharmacother 139:111708. https:\/\/doi.org\/10.1016\/j.biopha.2021.111708","journal-title":"Biomed Pharmacother"},{"key":"3073_CR42","doi-asserted-by":"publisher","unstructured":"Rios FJ, Touyz RM (2021) Mg2+\u00a0channels as the link between Mg2+\u00a0deficiency and COMT downregulation in salt-sensitive hypertension.\u00a0Hypertension (Dallas, Tex.: 1979)\u00a078(1):151\u2013154. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.121.17330","DOI":"10.1161\/HYPERTENSIONAHA.121.17330"},{"issue":"2","key":"3073_CR43","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1007\/s11864-020-00812-1","volume":"22","author":"M Russo","year":"2021","unstructured":"Russo M, Della A, Tocchetti CG, Porporato PE, Ghigo A (2021) Metabolic aspects of anthracycline cardiotoxicity. Curr Treat Options Oncol 22(2):18. https:\/\/doi.org\/10.1007\/s11864-020-00812-1","journal-title":"Curr Treat Options Oncol"},{"issue":"1","key":"3073_CR44","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1042\/cs0990027","volume":"99","author":"S Schmidt-Schweda","year":"2000","unstructured":"Schmidt-Schweda S, Holubarsch C (2000) First clinical trial with etomoxir in patients with chronic congestive heart failure. Clinss Sci (London, England: 1979) 99(1):27\u201335","journal-title":"Clinss Sci (London, England: 1979)"},{"issue":"5","key":"3073_CR45","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1007\/s00395-009-0015-5","volume":"104","author":"M Schwarzer","year":"2009","unstructured":"Schwarzer M, Faerber G, Rueckauer T, Blum D, Pytel G, Mohr W, Doenst T (2009) The metabolic modulators, Etomoxir and NVP-LAB121, fail to reverse pressure overload induced heart failure in vivo. Basic Res Cardiol 104(5):547\u2013557. https:\/\/doi.org\/10.1007\/s00395-009-0015-5","journal-title":"Basic Res Cardiol"},{"issue":"1","key":"3073_CR46","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1002\/cphy.c150016","volume":"6","author":"D Shao","year":"2015","unstructured":"Shao D, Tia R (2015) Glucose transporters in cardiac metabolism and hypertrophy. Comprehen Physiol 6(1):331\u2013351. https:\/\/doi.org\/10.1002\/cphy.c150016","journal-title":"Comprehen Physiol"},{"key":"3073_CR47","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.ijcard.2016.12.083","volume":"230","author":"L Szablewski","year":"2017","unstructured":"Szablewski L (2017) Glucose transporters in healthy heart and in cardiac disease. Int J Cardiol 230:70\u201375. https:\/\/doi.org\/10.1016\/j.ijcard.2016.12.083","journal-title":"Int J Cardiol"},{"issue":"2\u20133","key":"3073_CR48","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.vph.2009.06.002","volume":"51","author":"S Tofovic","year":"2009","unstructured":"Tofovic S, Zhang X, Jackson EK, Zhu H, Petrusevska G (2009) 2-methoxyestradiol attenuates bleomycin-induced pulmonary hypertension and fibrosis in estrogen-deficient rats. Vasc Pharmacol 51(2\u20133):190\u2013197. https:\/\/doi.org\/10.1016\/j.vph.2009.06.002","journal-title":"Vasc Pharmacol"},{"issue":"3","key":"3073_CR49","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1177\/030089168607200315","volume":"72","author":"F Villani","year":"1986","unstructured":"Villani F, Monti E, Piccinini F, Favalli L, Lanza E, Rozza Dionigi A, Poggi P (1986) Relationship between doxorubicin-induced ECG changes and myocardial alterations in rats. Tumori 72(3):323\u2013329. https:\/\/doi.org\/10.1177\/030089168607200315","journal-title":"Tumori"},{"issue":"4","key":"3073_CR50","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1161\/CIRCRESAHA.121.319901","volume":"130","author":"S Wilcox","year":"2022","unstructured":"Wilcox S, Rotz SJ, Mullen M, Song EJ, Ky Hamilton B, Moslehi J, Armenian SH, Wu JC, Rhe JW, Ky B (2022) Sex-specific cardiovascular risks of cancer and its therapies. Circ Res 130(4):632\u2013651. https:\/\/doi.org\/10.1161\/CIRCRESAHA.121.319901","journal-title":"Circ Res"},{"key":"3073_CR51","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.cbi.2015.12.010","volume":"244","author":"R Wu","year":"2016","unstructured":"Wu R, Wang HL, Yu HL, Cui XH, Xu MT, Xu X, Gao JP (2016) Doxorubicin toxicity changes myocardial energy metabolism in rats. Chemico-Biol Interact 244:149\u2013158. https:\/\/doi.org\/10.1016\/j.cbi.2015.12.010","journal-title":"Chemico-Biol Interact"},{"issue":"8","key":"3073_CR52","doi-asserted-by":"publisher","first-page":"2107","DOI":"10.1002\/ijc.32043","volume":"145","author":"S Yamamoto","year":"2019","unstructured":"Yamamoto S, Yamashita T, Ito M, Caaveiro JMM, Egashira N, Tozaki-Saitoh H, Tsuda M (2019) New pharmacological effect of fulvestrant to prevent oxaliplatin-induced neurodegeneration and mechanical allodynia in rats. Int J Cancer 145(8):2107\u20132113. https:\/\/doi.org\/10.1002\/ijc.32043","journal-title":"Int J Cancer"},{"issue":"5","key":"3073_CR53","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1203\/01.PDR.0000057988.62605.13","volume":"53","author":"HR Yoon","year":"2003","unstructured":"Yoon HR, Hong YM, Boriack RL, Bennett MJ (2003) Effect of L-carnitine supplementation on cardiac carnitine palmitoyltransferase activities and plasma carnitine concentrations in adriamycin-treated rats. Pediatric Res 53(5):788\u2013792. https:\/\/doi.org\/10.1203\/01.PDR.0000057988.62605.13","journal-title":"Pediatric Res"},{"issue":"5","key":"3073_CR54","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1208\/s12249-022-02298-6","volume":"23","author":"C Yu","year":"2022","unstructured":"Yu C, Li C, Pan H, Li T, He S (2022) Preparation of 2-Methoxyestradiol self-emulsified drug delivery system and the effect on combination therapy with doxorubicin against MCF-7\/ADM cells. AAPS PharmSciTech 23(5):147. https:\/\/doi.org\/10.1208\/s12249-022-02298-6","journal-title":"AAPS PharmSciTech"},{"issue":"6","key":"3073_CR55","doi-asserted-by":"publisher","first-page":"2960","DOI":"10.3390\/ijms23062960","volume":"23","author":"F Yu","year":"2022","unstructured":"Yu F, McLean B, Badiwala M, Billia F (2022) Heart failure and drug therapies: a metabolic review. Int J Mol Sci 23(6):2960. https:\/\/doi.org\/10.3390\/ijms23062960","journal-title":"Int J Mol Sci"},{"issue":"1","key":"3073_CR56","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s10557-012-6428-7","volume":"27","author":"W Yuan","year":"2013","unstructured":"Yuan W, Yu Y, Li J, Singh P, Li D, Gui Y, Zheng XL (2013) Estrogen metabolite 2-methoxyestradiol prevents hypertension in deoxycorticosterone acetate-salt rats. Cardiovasc Drugs Ther 27(1):17\u201322. https:\/\/doi.org\/10.1007\/s10557-012-6428-7","journal-title":"Cardiovasc Drugs Ther"},{"issue":"5","key":"3073_CR57","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1161\/CIRCHEARTFAILURE.112.000228","volume":"6","author":"L Zhang","year":"2013","unstructured":"Zhang L, Jaswal JS, Ussher JR, Sankaralingam S, Wagg C, Zaugg M, Lopaschuk GD (2013) Cardiac insulin-resistance and decreased mitochondrial energy production precede the development of systolic heart failure after pressure-overload hypertrophy. Circ Heart Fail 6(5):1039\u20131048. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.112.000228","journal-title":"Circ Heart Fail"},{"issue":"5","key":"3073_CR58","doi-asserted-by":"publisher","first-page":"2695","DOI":"10.3892\/mmr.2017.6332","volume":"15","author":"XJ Zhang","year":"2017","unstructured":"Zhang XJ, Cao XQ, Zhang CS, Zhao Z (2017) 17\u03b2-estradiol protects against doxorubicin-induced cardiotoxicity in male Sprague-Dawley rats by regulating NADPH oxidase and apoptosis genes. Mol Med Rep 15(5):2695\u20132702. https:\/\/doi.org\/10.3892\/mmr.2017.6332","journal-title":"Mol Med Rep"},{"issue":"5","key":"3073_CR59","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.3390\/molecules23051184","volume":"23","author":"R Zilinyi","year":"2018","unstructured":"Zilinyi R, Czompa A, Czegledi A, Gajtko A, Pituk D, Lekli I, Tosaki A (2018) The cardioprotective effect of metformin in doxorubicin-induced cardiotoxicity: the role of autophagy. Molecules (Basel, Switzerland) 23(5):1184. https:\/\/doi.org\/10.3390\/molecules23051184","journal-title":"Molecules (Basel, Switzerland)"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-024-03073-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-024-03073-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-024-03073-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,24]],"date-time":"2024-09-24T14:09:46Z","timestamp":1727186986000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-024-03073-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,23]]},"references-count":59,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["3073"],"URL":"https:\/\/doi.org\/10.1007\/s00210-024-03073-z","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,23]]},"assertion":[{"value":"24 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Institutional Animal Care and Use Committee, Cairo University (CU-IACUC), with an approval date of May 2023 and approval number CU III F 24 23.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}